Skip Navigation

Your Environment. Your Health.

National Institute of Environmental Health Sciences (NIEHS)
For more information about this archival news release, please contact Robin Mackar(http://www.niehs.nih.gov/news/media/index.cfm), News Director, Office of Communications & Public Liaison(http://www.niehs.nih.gov/about/od/ocpl/index.cfm) at (919) 541-0073 or by email at rmackar@niehs.nih.gov.
FOR IMMEDIATE RELEASE:
Friday, December 11, 2009
FOR MORE INFORMATION CONTACT:

Robin Mackar, NIH/NIEHS
(919) 541-0073

11 Dec 2009: News Advisory - Scientific Panel Evaluates Soy Infant Formula Safety

What

Members of the media are invited to attend a press availability period at noon on Friday, December 18, 2009 that will follow a scientific meeting evaluating the safety of soy infant formula. An independent panel of 14 scientists will evaluate the most current research on soy infant formula to determine whether exposure to soy infant formula is a risk to human development. The expert panel will also indentify data gaps and research needs. The panel is convened by the Center for the Evaluation of Risks to Human Reproduction (CERHR) of the National Institute of Environmental Health Sciences (NIEHS) and the National Toxicology Program (NTP).

 

Why

Soy formula is fed to infants as a supplement or replacement for human milk or cow milk. Soy infant formula contains isoflavones such as genistein, daidzein, and glycitein. These isoflavones are naturally occurring plant estrogens, or phytoestrogens, found at relatively high levels in soybeans and some other plants that can mimic the effects of estrogen in the body. The panel will review available evidence to determine if phytoestrogens in soy infant formula adversely affects human development. The panel will report its findings to the NTP.

 

The NTP convened a panel in 2006 to evaluate soy formula and genistein. The NTP did not complete the evaluation or issue a final opinion on this topic. Since 2006, a substantial number of new publications have been published for these substances, therefore NTP CERHR determined that an updated evaluation of soy formula is needed before NTP could develop its opinion on this topic. The panel will use all available information to issue new levels of concern conclusions about soy formula.

 

When

  • Wednesday, December 16, 8:30 a.m. to 5:00 p.m. EST (Time is set aside on December 16 for oral public comments, limited to seven minutes per speaker or organization.)
  • Thursday, December 17, 8:30 a.m. to 5:00 p.m. EST
  • Friday, December 18, 8:30 a.m. to noon EST
  • Press Availability: Friday, December 18, 2008, approximately noon to 1:00 p.m. EST

Where

The Hilton Alexandria Old Town
1767 King Street
Alexandria, VA 22314
Tel: 1–703–837–0440
http://www.alexandriahilton.com/  (http://www.alexandriahilton.com/)



More Information

The meeting is open to the public and the media. Details about the meeting, including panelists and agenda, are posted on the NTP Web site at http://cerhr.niehs.nih.gov/evals/genistein-soy/SoyFormulaUpdt/SoyFormula-mtg.html  .

 

Contact

Media interested in attending the meeting or the press availability can contact Robin Mackar at 919-541-0073 or e-mail your request to rmackar@niehs.nih.gov (mailto:rmackar@niehs.nih.gov) .


NIEHS supports research to understand the effects of the environment on human health and is part of the National Institutes of Health (NIH). For more information on environmental health topics, visit our website at http://www.niehs.nih.gov (http://www.niehs.nih.gov) .

 

The NTP is an interagency program established in 1978. The program was created as a cooperative effort to coordinate toxicology testing programs within the federal government, strengthen the science base in toxicology, develop and validate improved testing methods, and provide information about potentially toxic chemicals to health, regulatory, and research agencies, scientific and medical communities, and the public. The NTP is headquartered at the NIEHS. For more information about the NTP, visit http://ntp.niehs.nih.gov  .

 

The National Institutes of Health (NIH) — The Nation's Medical Research Agency — includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov  .



Back to top Back to top

Back to Top